Helicobacter Pylori Infection Associated with an Increased Risk of Colorectal Adenomatous Polyps in the Chinese Population

Overview

Journal BMC Gastroenterol

Publisher Biomed Central

Specialty Gastroenterology

Date 2019 Jan 23

PMID 30665367

Citations 17

Authors

ChangxiChen

Yushan Mao

Juan Du

Yimin Xu

Zhongwei Zhu

Hongbao Cao

Affiliations

Soon will be listed here.

Abstract

Background: Gastric Helicobacter pylori (H. pylori) is linked with chronic gastritis, peptic ulcer disease, and gastric malignancy. This study aims to investigate the association of gastric H. pylori with colorectal adenomatous polyps (CAP) in the Chinese population.

Methods: One thousand three hundred seventy five workers of China Petroleum and Chemical Corporation Sinopec Zhenhai Refining & Chemical Branch were recruited. Carbon-13 urea breathes test, and colorectal biopsies were utilized to detect H. pylori and CAP. The correlation between the number and distribution of CAP with H. pylori infection (HPI) was determined. Logistic regression models were applied to calculate the effect of H. pylori on the risk of CAP and pathway studio was used to attribute the cellular processes linking HPI and adenomatous polyps.

Results: One hundred Eighty participants were diagnosed as CAP, and 1195 participants were classified as healthy control. The prevalence of HPI in the CAP group was significantly higher than that in the healthy control group (57.8% verse 40.1%) (p<0.001). It was the number not the distribution of CAP corrected with H. pylori status. An increased risk of CAP was found to be associated with H. pylori (OR = 3.237; 95.0% CI 2.184-4.798, p = 0.00) even after multiple parameters adjustment. Pathway studio analysis demonstrated that HPI connected with CAP at multi-level.

Conclusions: HPI is associated with an increased risk of CAP in the Chinese population.

Citing Articles

Relationship between infection and digestive tract diseases and analysis of risk factors: a cross-sectional study based on 3867 Chinese patients.

Zhao W, Han Y, Xiao Y, Liu Y, Zhang Z, Liao L Aging (Albany NY). 2024; 16(16):11917-11925.

PMID: 39177658 PMC: 11386919. DOI: 10.18632/aging.206065.

Serum microRNA Levels as a Biomarker for Diagnosing Non-Alcoholic Fatty Liver Disease in Chinese Colorectal Polyp Patients.

Ng L, Sin R, Cheung D, Leung W, Man A, Lo O Int J Mol Sci. 2023; 24(10).

PMID: 37240431 PMC: 10218925. DOI: 10.3390/ijms24109084.

Association of D299G Polymorphism of TLR4 Gene and CagA Virulence Factor of H. pylori among the Iranian Patients with Colorectal Cancer.

Malallah Ghayemi S, Aboutaleb N, Yousefi G, Mousavi-Niri N, Naseroleslami M Med J Islam Repub Iran. 2022; 36:96.

PMID: 36419946 PMC: 9680813. DOI: 10.47176/mjiri.36.96.

Establish a Novel Model for Predicting the Risk of Colorectal Ademomatous Polyps: a Prospective Cohort Study.

Li W, Chen Z, Chen H, Han X, Zhang G, Zhou X J Cancer. 2022; 13(10):3103-3112.

PMID: 36046645 PMC: 9414019. DOI: 10.7150/jca.74772.

Tumor Microenvironment Shapes Colorectal Cancer Progression, Metastasis, and Treatment Responses.

Li J, Chen D, Shen M Front Med (Lausanne). 2022; 9:869010.

PMID: 35402443 PMC: 8984105. DOI: 10.3389/fmed.2022.869010.

References

Xu Z, Zhang J, Yang D, Zhang J . [Progress of research between Helicobacter pylori infection and osteoporosis]. Zhongguo Gu Shang. 2012; 24(11):966-8. View

Groblewska M, Mroczko B, Gryko M, Kedra B, Szmitkowski M . Matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in the diagnosis of colorectal adenoma and cancer patients. Folia Histochem Cytobiol. 2011; 48(4):564-71. DOI: 10.2478/v10042-010-0076-1. View

Crawford-Williams F, March S, Ireland M, Rowe A, Goodwin B, Hyde M . Geographical Variations in the Clinical Management of Colorectal Cancer in Australia: A Systematic Review. Front Oncol. 2018; 8:116. PMC: 5965390. DOI: 10.3389/fonc.2018.00116. View

Patel S, Lipka S, Shen H, Barnowsky A, Silpe J, Mosdale J . The association of H. pylori and colorectal adenoma: does it exist in the US Hispanic population?. J Gastrointest Oncol. 2014; 5(6):463-8. PMC: 4226815. DOI: 10.3978/j.issn.2078-6891.2014.074. View

Kountouras J, Kapetanakis N, Polyzos S, Katsinelos P, Gavalas E, Tzivras D . Active Infection Is a Risk Factor for Colorectal Mucosa: Early and Advanced Colonic Neoplasm Sequence. Gut Liver. 2017; 11(5):733-734. PMC: 5593337. DOI: 10.5009/gnl16389. View

Moss S, Neugut A, Garbowski G, Wang S, Treat M, Forde K . Helicobacter pylori seroprevalence and colorectal neoplasia: evidence against an association. J Natl Cancer Inst. 1995; 87(10):762-3. DOI: 10.1093/jnci/87.10.762. View

Duris I, Hruby D, Pekarkova B, Huorka M, Cernakova E, Bezayova T . Calcium chemoprevention in colorectal cancer. Hepatogastroenterology. 1996; 43(7):152-4. View

Dolatkhah R, Somi M, Asvadi Kermani I, Ghojazadeh M, Jafarabadi M, Farassati F . Increased colorectal cancer incidence in Iran: a systematic review and meta-analysis. BMC Public Health. 2015; 15:997. PMC: 4589975. DOI: 10.1186/s12889-015-2342-9. View

Hyman N, Anderson P, Blasyk H . Hyperplastic polyposis and the risk of colorectal cancer. Dis Colon Rectum. 2005; 47(12):2101-4. DOI: 10.1007/s10350-004-0709-6. View

10.

Marmol I, Sanchez-de-Diego C, Pradilla Dieste A, Cerrada E, Rodriguez Yoldi M . Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer. Int J Mol Sci. 2017; 18(1). PMC: 5297828. DOI: 10.3390/ijms18010197. View

11.

Hu K, Wu M, Chu C, Wang H, Lin S, Po H . Hyperglycemia combined infection increases risk of synchronous colorectal adenoma and carotid artery plaque. Oncotarget. 2018; 8(65):108655-108664. PMC: 5752471. DOI: 10.18632/oncotarget.22094. View

12.

Brenner H, Zwink N, Ludwig L, Hoffmeister M . Should Screening Colonoscopy Be Offered From Age 50?. Dtsch Arztebl Int. 2017; 114(6):94-100. PMC: 5341112. DOI: 10.3238/arztebl.2017.0094. View

13.

Mommersteeg M, Yu J, Peppelenbosch M, Fuhler G . Genetic host factors in Helicobacter pylori-induced carcinogenesis: Emerging new paradigms. Biochim Biophys Acta Rev Cancer. 2017; 1869(1):42-52. DOI: 10.1016/j.bbcan.2017.11.003. View

14.

Cottet V, Jooste V, Fournel I, Bouvier A, Faivre J, Bonithon-Kopp C . Long-term risk of colorectal cancer after adenoma removal: a population-based cohort study. Gut. 2011; 61(8):1180-6. DOI: 10.1136/gutjnl-2011-300295. View

15.

Nikitin A, Egorov S, Daraselia N, Mazo I . Pathway studio--the analysis and navigation of molecular networks. Bioinformatics. 2003; 19(16):2155-7. DOI: 10.1093/bioinformatics/btg290. View

16.

Moss S, Calam J . Helicobacter pylori and peptic ulcers: the present position. Gut. 1992; 33(3):289-92. PMC: 1373812. DOI: 10.1136/gut.33.3.289. View

17.

Nguyen H, Duong H . The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy. Oncol Lett. 2018; 16(1):9-18. PMC: 6006272. DOI: 10.3892/ol.2018.8679. View

18.

Jang T . The number of Foxp3-positive regulatory T cells is increased in Helicobacter pylori gastritis and gastric cancer. Pathol Res Pract. 2009; 206(1):34-8. DOI: 10.1016/j.prp.2009.07.019. View

19.

Lu J, Hu X, Meng Y, Zhao H, Cao Q, Jin M . The prognosis significance and application value of peritoneal elastic lamina invasion in colon cancer. PLoS One. 2018; 13(4):e0194804. PMC: 5890982. DOI: 10.1371/journal.pone.0194804. View

20.

Kountouras J, Kapetanakis N . CD44 and Helicobacter pylori-related colon oncogenesis. Saudi Med J. 2015; 36(10):1249. PMC: 4621736. DOI: 10.15537/smj.2015.10.12510. View